Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 11;40(1):163.
doi: 10.1186/s13046-021-01955-1.

What are the applications of single-cell RNA sequencing in cancer research: a systematic review

Affiliations

What are the applications of single-cell RNA sequencing in cancer research: a systematic review

Lvyuan Li et al. J Exp Clin Cancer Res. .

Abstract

Single-cell RNA sequencing (scRNA-seq) is a tool for studying gene expression at the single-cell level that has been widely used due to its unprecedented high resolution. In the present review, we outline the preparation process and sequencing platforms for the scRNA-seq analysis of solid tumor specimens and discuss the main steps and methods used during data analysis, including quality control, batch-effect correction, normalization, cell cycle phase assignment, clustering, cell trajectory and pseudo-time reconstruction, differential expression analysis and gene set enrichment analysis, as well as gene regulatory network inference. Traditional bulk RNA sequencing does not address the heterogeneity within and between tumors, and since the development of the first scRNA-seq technique, this approach has been widely used in cancer research to better understand cancer cell biology and pathogenetic mechanisms. ScRNA-seq has been of great significance for the development of targeted therapy and immunotherapy. In the second part of this review, we focus on the application of scRNA-seq in solid tumors, and summarize the findings and achievements in tumor research afforded by its use. ScRNA-seq holds promise for improving our understanding of the molecular characteristics of cancer, and potentially contributing to improved diagnosis, prognosis, and therapeutics.

Keywords: Data analysis; Sequencing platform; Single-cell RNA sequencing; Specimen preparation; Tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Williams MJ, Werner B, Heide T, et al. Quantification of subclonal selection in cancer from bulk sequencing data. Nat Genet. 2018;50(6):895–903. 10.1038/s41588-018-0128-6. - PMC - PubMed
    1. Tang F, Barbacioru C, Wang Y, et al. mRNA-seq whole-transcriptome analysis of a single cell. Nat Methods. 2009;6(5):377–82. 10.1038/nmeth.1315. - PubMed
    1. Suva ML, Tirosh I. Single-cell RNA sequencing in cancer: lessons learned and emerging challenges. Mol Cell. 2019;75(1):7–12. 10.1016/j.molcel.2019.05.003. - PubMed
    1. Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352(6282):189–96. 10.1126/science.aad0501. - PMC - PubMed
    1. Shalek AK, Satija R, Shuga J, et al. Single-cell RNA-seq reveals dynamic paracrine control of cellular variation. Nature. 2014;510(7505):363–9. 10.1038/nature13437. - PMC - PubMed

Publication types